Literature DB >> 28842318

Stimulus-responsive viral vectors for controlled delivery of therapeutics.

Mitchell J Brun1, Eric J Gomez2, Junghae Suh3.   

Abstract

Virus-based therapies have gained momentum as the next generation of treatments for a variety of serious diseases. In order to make these therapies more controllable, stimulus-responsive viral vectors capable of sensing and responding to specific environmental inputs are currently being developed. A number of viruses naturally respond to endogenous stimuli, such as pH, redox, and proteases, which are present at different concentrations in diseases and at different organ and organelle sites. Additionally, rather than relying on natural viral properties, efforts are underway to engineer viruses to respond to endogenous stimuli in new ways as well as to exogenous stimuli, such as temperature, magnetic field, and optical light. Viruses with stimulus-responsive capabilities, either nature-evolved or human-engineered, will be reviewed to capture the current state of the field. Stimulus-responsive viral vector design considerations as well as gaps in current research efforts will be identified.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bioactivatable; Bioresponsive; Gene delivery; Gene therapy; Viral vector

Mesh:

Substances:

Year:  2017        PMID: 28842318      PMCID: PMC5723212          DOI: 10.1016/j.jconrel.2017.08.021

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  99 in total

1.  Photoactivatable retroviral vectors: a strategy for targeted gene delivery.

Authors:  M W Pandori; T Sano
Journal:  Gene Ther       Date:  2000-12       Impact factor: 5.250

Review 2.  Phytochromes and light signal perception by plants--an emerging synthesis.

Authors:  H Smith
Journal:  Nature       Date:  2000-10-05       Impact factor: 49.962

3.  Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo.

Authors:  F Scherer; M Anton; U Schillinger; J Henke; C Bergemann; A Krüger; B Gänsbacher; C Plank
Journal:  Gene Ther       Date:  2002-01       Impact factor: 5.250

4.  Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors.

Authors:  C Hughes; J Galea-Lauri; F Farzaneh; D Darling
Journal:  Mol Ther       Date:  2001-04       Impact factor: 11.454

Review 5.  New functions for the matrix metalloproteinases in cancer progression.

Authors:  Mikala Egeblad; Zena Werb
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

6.  A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.

Authors:  J M Binley; R W Sanders; B Clas; N Schuelke; A Master; Y Guo; F Kajumo; D J Anselma; P J Maddon; W C Olson; J P Moore
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Proteolytic activation of respiratory syncytial virus fusion protein. Cleavage at two furin consensus sequences.

Authors:  G Zimmer; L Budz; G Herrler
Journal:  J Biol Chem       Date:  2001-06-19       Impact factor: 5.157

8.  Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates.

Authors:  W D Hunter; R L Martuza; F Feigenbaum; T Todo; T Mineta; T Yazaki; M Toda; J T Newsome; R C Platenberg; H J Manz; S D Rabkin
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.

Authors:  H Yamamoto; F Itoh; S Iku; Y Adachi; H Fukushima; S Sasaki; M Mukaiya; K Hirata; K Imai
Journal:  J Clin Oncol       Date:  2001-02-15       Impact factor: 44.544

10.  Adenoviral-mediated suicide gene therapy for ovarian cancer.

Authors:  R D Alvarez; J Gomez-Navarro; M Wang; M N Barnes; T V Strong; R B Arani; W Arafat; J V Hughes; G P Siegal; D T Curiel
Journal:  Mol Ther       Date:  2000-11       Impact factor: 11.454

View more
  6 in total

1.  Generation of a caged lentiviral vector through an unnatural amino acid for photo-switchable transduction.

Authors:  Yan Wang; Shuai Li; Zhenyu Tian; Jiaqi Sun; Shuobin Liang; Bo Zhang; Lu Bai; Yuanjie Zhang; Xueying Zhou; Sulong Xiao; Qiang Zhang; Lihe Zhang; Chuanling Zhang; Demin Zhou
Journal:  Nucleic Acids Res       Date:  2019-11-04       Impact factor: 16.971

Review 2.  Physical, chemical, and synthetic virology: Reprogramming viruses as controllable nanodevices.

Authors:  Maria Yanqing Chen; Susan S Butler; Weitong Chen; Junghae Suh
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2018-11-08

3.  Longer Inactivating Sequence in Peptide Lock Improves Performance of Synthetic Protease-Activatable Adeno-Associated Virus.

Authors:  Maria Y Chen; Tawana M Robinson; Junghae Suh
Journal:  ACS Synth Biol       Date:  2019-01-07       Impact factor: 5.110

4.  Electrochemical dopamine sensor based on the use of a thermosensitive polymer and an nanocomposite prepared from multiwalled carbon nanotubes and graphene oxide.

Authors:  Pengcheng Zhao; Chao Chen; Meijun Ni; Longqi Peng; Chunyan Li; Yixi Xie; Junjie Fei
Journal:  Mikrochim Acta       Date:  2019-02-01       Impact factor: 5.833

Review 5.  Plant Virus Nanoparticles for Anti-cancer Therapy.

Authors:  Srividhya Venkataraman; Paul Apka; Erum Shoeb; Uzma Badar; Kathleen Hefferon
Journal:  Front Bioeng Biotechnol       Date:  2021-12-15

Review 6.  Biodegradable Polymers for Gene Delivery.

Authors:  T J Thomas; Heidar-Ali Tajmir-Riahi; C K S Pillai
Journal:  Molecules       Date:  2019-10-17       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.